Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $575

Benzinga Newsdesk www.benzinga.com Positive 67.3%

Neg 0% Neu 0% Pos 67.3%

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target from $486 to $575.